Sitagliptin Linked to Higher HF Risk

(MedPage Today) -- In patients with type 2 diabetes and heart failure, the use of sitagliptin (Januvia) was associated with greater risk of hospitalization for heart failure, a study based on insurance claims showed.
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news